Solomon reports research grants from Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, Bristol Myers Squibb, Boston Scientific, Cytokinetics, Edgewise, Eidos/BridgeBio, Gossamer, GlaxoSmithKline, Ionis, Eli Lilly, the National Institutes of Health/National Heart, Lung, and Blood Institute, Novartis, Novo Nordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, and YS2.AI
A notable new side effect was dysesthesia (skin tingling or sensitivity), reported in about 21% of patients on the highest dose, though generally mild
Attempts to redefine these terms in the endocrinology field and diabetes sub terminology, may potentially create more ambiguity
However, some individuals with hypothyroidism may continue to experience symptoms even with proper treatment
*Real results from real Alternate Health Club customers